Prophase Labs, Inc. Announces Resignation of Robert V. Cuddihy as Chief Financial Officer and Chief Accounting Officer
August 25, 2017 at 01:52 am IST
Share
On August 22, 2017, Robert V. Cuddihy the Chief Financial Officer and Chief Accounting Officer of ProPhase Labs, Inc. notified the company of his intention to resign his positions with the company in order to pursue other career opportunities that have been offered to him. Mr. Cuddihy has agreed to continue in his employment with the Company and his role as Chief Financial Officer and Chief Accounting Officer until September 29, 2017.
ProPhase Labs, Inc. is a biopharma, genomics, and diagnostics company. The Company provides whole genome sequencing solutions, while developing potential diagnostics and therapeutics in the fight against cancer. This includes a potentially life-saving cancer test focused on early detection of esophageal cancer and potential breakthrough cancer therapeutics with novel mechanisms of action. Its segments include diagnostic services and consumer products. The diagnostic services segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third party payers and government organizations. The consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of over-the-counter consumer healthcare products and dietary supplements in the United States and also provides personal genomics products and services. Its CLIA labs and diagnostic technology provide wellness solutions.
PROPHASE LABS, INC. 
